Beam Therapeutics Inc (BEAM)

09:05 AM

Prime Medicine wins Beam Therapeutics arbitration (PRME:NASDAQ) - Seeking Alpha

09:05 AM

08:05 AM

Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics - The Manila Times

08:05 AM

08:00 AM

Prime Medicine clears Beam dispute, keeps PM647 for AATD - Stock Titan

08:00 AM

05:07 AM

Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal - Yahoo Finance

05:07 AM

Jul 07, 2026

H.C. Wainwright reiterates Beam Therapeutics stock rating on BLA progress - Investing.com

Jul 07, 2026

Jul 07, 2026

Russell Value Index Additions Could Be A Game Changer For Beam Therapeutics (BEAM) - simplywall.st

Jul 07, 2026

Jul 06, 2026

Beam Therapeutics stock hits 52-week high at 36.89 USD - Investing.com

Jul 06, 2026

Jul 06, 2026

Beam Therapeutics stock hits 52-week high at 36.89 USD By Investing.com - Investing.com South Africa

Jul 06, 2026

Jul 05, 2026

Understanding the Setup: (BEAM) and Scalable Risk - Stock Traders Daily

Jul 05, 2026

Jul 04, 2026

Beam Therapeutics Inc. Stock 12‑Month Price Target Cut to $49.87, Implies 43% Upside - TradingView

Jul 04, 2026

Jul 03, 2026

FMR LLC Reduces Stake in Beam Therapeutics Inc. - GuruFocus

Jul 03, 2026

Jul 02, 2026

Beam Therapeutics (NASDAQ: BEAM) CMO sells 373 shares for tax withholding - Stock Titan

Jul 02, 2026

Jul 02, 2026

BEAMBeam Therapeutics Inc Latest SEC Filings - Finviz

Jul 02, 2026

Jul 02, 2026

BEAM Stock Price, Quote & Chart - ChartMill

Jul 02, 2026

Jul 01, 2026

Beam Therapeutics (BEAM) CEO exercises options and sells 50K shares under plan - Stock Titan

Jul 01, 2026

Jul 01, 2026

BEAM Stock's Gains Fade Despite Promising Data Rare Liver Disease Treatment Data - Stocktwits

Jul 01, 2026

Jun 30, 2026

Form 144 BEAM THERAPEUTICS INC. For: 30 June By Investing.com - Investing.com Nigeria

Jun 30, 2026

Jun 30, 2026

Hedge Fund and Insider Trading News: Paul Singer, Warren Buffett, Ray Dalio, George Soros, Millennium Management, Point72 Asset Management, Citadel Investment Group, CG Oncology Inc (CGON), Beam Therapeutics Inc (BEAM), and More - Insider Monkey

Jun 30, 2026

Jun 29, 2026

BEAM News | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill

Jun 29, 2026

Jun 29, 2026

Beam Therapeutics(BEAM.US) 10% Shareholder Sells US$10.04 Million in Common Stock - Moomoo

Jun 29, 2026

Jun 29, 2026

Form 144 BEAM THERAPEUTICS INC. For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

FMR LLC sells $10.04 million in Beam Therapeutics shares By Investing.com - Investing.com Australia

Jun 29, 2026

Jun 29, 2026

BEAM (NASDAQ: BEAM) insider files to sell 25,000 shares via option exercise - Stock Titan

Jun 29, 2026

Jun 29, 2026

Form 4 Beam Therapeutics Inc For: 29 June By Investing.com - Investing.com Nigeria

Jun 29, 2026

Jun 29, 2026

FMR LLC sells $10.04 million in Beam Therapeutics shares - Investing.com

Jun 29, 2026

Jun 29, 2026

FMR LLC (BEAM) trims Beam Therapeutics stake with 284,860-share open-market sale - Stock Titan

Jun 29, 2026

Jun 29, 2026

Beam Therapeutics Inc.(NasdaqGS: BEAM) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Beam Therapeutics Inc.(NasdaqGS: BEAM) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 28, 2026

Beam Therapeutics Inc.(NasdaqGS:BEAM) added to Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade) (NASDAQ:BEAM) - Seeking Alpha

Jun 26, 2026

Jun 26, 2026

Beam Therapeutics, Inc. Actuals & Estimates (NASDAQ:BEAM) - TradingView

Jun 26, 2026

Jun 26, 2026

BEAM Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

Beam Therapeutics, Inc. Actuals & Estimates (BMV:BEAM) - TradingView

Jun 26, 2026

Jun 25, 2026

Price to sales forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView

Jun 25, 2026

Jun 25, 2026

Enterprise value to EBIT forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView

Jun 25, 2026

Jun 25, 2026

Enterprise value to revenue forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView

Jun 25, 2026

Jun 25, 2026

Price to book forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView

Jun 25, 2026

Jun 25, 2026

Enterprise value to EBITDA forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView

Jun 25, 2026

Jun 25, 2026

Price to earnings forward of Beam Therapeutics Inc. – NASDAQ:BEAM - TradingView

Jun 25, 2026

Jun 25, 2026

Beam Therapeutics (BEAM) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Jun 25, 2026

Jun 24, 2026

The Technical Signals Behind (BEAM) That Institutions Follow - Stock Traders Daily

Jun 24, 2026

Jun 23, 2026

Wedbush Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $65 - Moomoo

Jun 23, 2026

Jun 22, 2026

Beam Therapeutics stock soars 21% in three months: Here's why - MSN

Jun 22, 2026

Jun 22, 2026

Beam Therapeutics president exercises 35,505 options | BEAM Insider Trading - Stock Titan

Jun 22, 2026

Jun 22, 2026

Beam Therapeutics stock hits 52-week high at 36.66 USD By Investing.com - Investing.com Australia

Jun 22, 2026

Jun 22, 2026

Beam Therapeutics stock hits 52-week high at 36.66 USD - Investing.com

Jun 22, 2026

Jun 22, 2026

Clinical: Beam Advances Base Editing For PKU - CRISPR Medicine News

Jun 22, 2026

Jun 21, 2026

Beam Therapeutics Inc (BEAM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 21, 2026

Jun 19, 2026

BEAM Stock Gains 5% as FDA Clears BEAM-304 IND for Phenylketonuria - The Globe and Mail

Jun 19, 2026